Capstone Therapeutics Corp
Capstone Holding Corp., through its subsidiaries, engages in the distribution of masonry stone products in the United States. Its masonry stone products include manufactured and natural stone cladding products, natural stone landscape products and related goods for residential and commercial construction. The company was formerly known as Capstone Therapeutics Corp. and changed its name to Capsto… Read more
Market Cap & Net Worth: Capstone Therapeutics Corp (CAPS)
Capstone Therapeutics Corp (OTCQB:CAPS) has a market capitalization of $302.61K ($302.61K) as of March 18, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #41506 globally and #13489 in its home market, demonstrating a -31.43% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Capstone Therapeutics Corp's stock price $1.92 by its total outstanding shares 157610 (157.61K).
Capstone Therapeutics Corp Market Cap History: 2015 to 2025
Capstone Therapeutics Corp's market capitalization history from 2015 to 2025. Data shows change from $20.49 Million to $302.61K (-37.00% CAGR).
Index Memberships
Capstone Therapeutics Corp is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.00% | #929 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #2892 of 3165 |
Weight: Capstone Therapeutics Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Capstone Therapeutics Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Capstone Therapeutics Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
Capstone Therapeutics Corp's market cap is 0.02 times its annual revenue
0.21x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $2.84 Million | $2.00 Million | -$380.00K | 1.42x | N/A |
| 2019 | $2.36 Million | $13.97 Million | -$2.07 Million | 0.17x | N/A |
| 2020 | $5.36 Million | $45.45 Million | $10.46 Million | 0.12x | 0.51x |
| 2021 | $2.72 Million | $66.74 Million | $3.92 Million | 0.04x | 0.69x |
| 2022 | $5.83 Million | $61.56 Million | $2.31 Million | 0.09x | 2.52x |
| 2023 | $819.57K | $48.35 Million | -$3.82 Million | 0.02x | N/A |
Competitor Companies of CAPS by Market Capitalization
Companies near Capstone Therapeutics Corp in the global market cap rankings as of March 18, 2026.
Key companies related to Capstone Therapeutics Corp by market ranking:
- Holcim Ltd (PINK:HCMLF): Ranked #438 globally with a market cap of $49.46 Billion USD.
- Martin Marietta Materials Inc (NYSE:MLM): Ranked #603 globally with a market cap of $34.84 Billion USD.
- Holcim AG (SW:HOLN): Ranked #604 globally with a market cap of $34.75 Billion USD ( CHF31.82 Billion CHF).
- Vulcan Materials Company (NYSE:VMC): Ranked #606 globally with a market cap of $34.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #438 | Holcim Ltd | PINK:HCMLF | $49.46 Billion | $100.00 |
| #603 | Martin Marietta Materials Inc | NYSE:MLM | $34.84 Billion | $582.50 |
| #604 | Holcim AG | SW:HOLN | $34.75 Billion | CHF64.04 |
| #606 | Vulcan Materials Company | NYSE:VMC | $34.56 Billion | $265.46 |
Capstone Therapeutics Corp Historical Marketcap From 2015 to 2025
Between 2015 and today, Capstone Therapeutics Corp's market cap moved from $20.49 Million to $ 302.61K, with a yearly change of -37.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $302.61K | -40.00% |
| 2024 | $504.35K | -38.46% |
| 2023 | $819.57K | -85.95% |
| 2022 | $5.83 Million | +114.49% |
| 2021 | $2.72 Million | -49.26% |
| 2020 | $5.36 Million | +126.67% |
| 2019 | $2.36 Million | -16.67% |
| 2018 | $2.84 Million | -60.00% |
| 2017 | $7.09 Million | -35.71% |
| 2016 | $11.03 Million | -46.15% |
| 2015 | $20.49 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Capstone Therapeutics Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $302.61K USD |
| MoneyControl | $302.61K USD |
| MarketWatch | $302.61K USD |
| marketcap.company | $302.61K USD |
| Reuters | $302.61K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.